IMD™ logo

IMD™

A molecular and pathology technical company Empowering and Enabling independent pathology practices.

31 employees · est. 2016 · Berkeley, United States

VS
Paige logo

Paige

Now a Tempus company | Bridging Vision & Precision

38 employees · est. 2018 · United States

IMD™ is the older company (2016 vs 2018).

Side-by-Side Comparison

IMD™ Paige
Founded
2016 older 2018
Headquarters
Berkeley, United States United States
Employees
31 38
Industry
Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Not tracked yet Acquired
Total Funding
Not tracked yet $220.75M
Funding Rounds
Not tracked yet 7
Services
Not tracked yet AI-Assisted Diagnostic and Biomarker Applications, AI Technology Licensing, Custom AI Development, Regulatory Strategy Consulting, Commercialization Services
Target Customers
Not tracked yet Pathologists, Healthcare Providers, Clinical Researchers, Pharmaceutical Companies
Taxonomy
Molecular Diagnostics, Pathology, Oncology, Cancer Diagnostic, Prognostic Models, Genetic Blueprints, Esoteric Testing, High Complexity Molecular Diagnostics, Women's Health, Technical Molecular, Integrated Delivery Networks, Clinical Laboratories, Diagnostic Services, Anschutz Medical Campus, Independent Pathology Practices Computational Pathology, Digital Pathology, Clinical-Grade AI, Diagnostic AI, Cancer Detection, Biomarker Development, Diagnostic Support, Clinical Trial Enrichment, Algorithm Development, AI In Healthcare, FDA Approved AI, Cloud-Based Platform, Pathologists Workflow Enhancement, Patient Data Privacy, Pharmaceutical Collaboration
Website
imdpath.com paige.ai
IMD™ logo

About IMD™

IMD™ is a molecular and pathology technical company that aims to empower and enable independent pathology practices. Founded in 2016, IMD Path operates two facilities in Berkeley, CA, and Denver, CO, equipped with state-of-the-art technology and testing capabilities. The company's focus lies in revo...

Paige logo

About Paige

Paige, now a part of Tempus, is trailblazing the field of oncology by leveraging the power of AI to enhance cancer discovery and treatment. Founded in 2018, this United States-based company operates at the intersection of Biopharma, Biotechnology, and Health Care. By creating a cloud-based platform,...

We will tell you when either one moves

BounceWatch watches IMD™ and Paige for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at IMD™ and Paige — by email.

Frequently Asked Questions

IMD™ — A molecular and pathology technical company Empowering and Enabling independent pathology practices.. Paige — Now a Tempus company | Bridging Vision & Precision . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
IMD™ has raised undisclosed funding while Paige has raised $220.75M.
IMD™ and Paige operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare IMD™ with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at IMD™ on 14 Nov 2024, and Paige on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy